

( (S (NP-SBJ (NP (NP Bristol-Myers Squibb Co.)
                 ,
                 (NP-LOC New York)
                 ,)
             (NP the 
		 (ADJP newly merged) 
		 drug and health-care-product company)
             ,)
     (VP reported
         (NP (NP record third-quarter earnings)
             (PP for
                 (NP (NP both companies)
                     (PP-LOC in
			     (NP the merger))))))
     .))
( (S (S (NP-SBJ (NP Bristol-Myers Co.)
		and
		(NP (NP Squibb Corp.)
		    ,
		    (NP-LOC (NP Princeton)
			    ,
			    (NP N.J.)
			    ,)))
        (VP merged
	    (NP-TMP Oct. 4)))
     , 
     but
     (S (NP-SBJ the new company)
        (VP reported
            (NP (NP third-period earnings)
		(PP for
		    (NP both companies)))))
     .))
( (S (PP-TMP For
	     (NP the fourth quarter))
     ,
     (NP-SBJ Bristol-Myers Squibb)
     (VP will
         (VP report
             (NP (NP one set)
                 (PP of
                     (NP earnings)))))
     .))
( (S (NP-SBJ Bristol-Myers)
     (VP said
         (SBAR 0
               (S (NP-SBJ net income)
                  (VP rose
                      (NP-EXT 15 %)
                      (PP-DIR to
			      (NP (NP (QP $ 266.2 million) *U*)
				  , 
				  or
				  (NP (NP 93 cents)
				      (NP-ADV a share))
				  ,))
		      (PP-DIR from
			      (NP (NP (QP $ 232.3 million) *U*)
				  , 
				  or
				  (NP (NP 81 cents)
				      (NP-ADV a share))
				  ,)
			      (ADVP-TMP (NP a year)
					earlier))))))
     .))
( (S (NP-SBJ Sales)
     (VP gained
         (NP 5 %)
         (PP-DIR to
		 (NP (QP $ 1.59 billion) *U*))
	 (PP-DIR from
		 (NP (QP $ 1.52 billion) *U*)))
     .))
( (S (NP-SBJ Squibb Corp.)
     (VP said
         (SBAR 0
               (S (NP-SBJ net)
                  (VP rose
                      (NP-EXT 17 %)
                      (PP-DIR to
			      (NP (NP (QP $ 144.5 million) *U*)
				  , 
				  or
				  (NP (NP $ 1.47 *U*)
				      (NP-ADV a share))
				  ,))
		      (PP-DIR from
			      (NP (NP (QP $ 123 million) *U*)
				  , 
				  or
				  (NP (NP $ 1.25 *U*)
				      (NP-ADV a share))))))))
     .))
( (S (NP-SBJ Sales)
     (VP were
         (NP-PRD (QP $ 730.1 million) *U*)
         ,
         (ADVP up
               (NP 7 %)
               (PP from
                   (NP (QP $ 679.5 million) *U*))))
     .))
( (S (PP-LOC In
	     (NP New York Stock Exchange composite trading))
     ,
     (NP-SBJ Bristol-Myers Squibb)
     (VP rose
         (NP-EXT $ 1.75 *U*)
         (PP-DIR to
		 (NP $ 52.75 *U*)))
     .))
